Showing 1 to 1 of 1 results
kathimerini.gr
🌐 85% Global Worthiness
GLP-1 Agonist Shows Significant Promise in Treating Obstructive Sleep Apnea
A year-long study published in The New England Journal of Medicine showed that tirzepatide, a GLP-1 agonist, reduced the apnea-hypopnea index by almost 59% in 469 obese individuals with moderate-to-severe obstructive sleep apnea, alongside an average 20% weight loss; this may reduce reliance on CPAP...
GLP-1 Agonist Shows Significant Promise in Treating Obstructive Sleep Apnea
A year-long study published in The New England Journal of Medicine showed that tirzepatide, a GLP-1 agonist, reduced the apnea-hypopnea index by almost 59% in 469 obese individuals with moderate-to-severe obstructive sleep apnea, alongside an average 20% weight loss; this may reduce reliance on CPAP...
Progress
48% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results